Targeted therapy in children—what is the right way? (Q62066932)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21750513%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Nonalcoholic fatty liver disease: Targeted therapy in children--what is the right way? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21750513%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21750513%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Valerio Nobili

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21750513%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1

Anna Alisi

0 references

author name string

Valerio Nobili

series ordinal

2

0 references

language of work or name

English

0 references

publication date

12 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21750513%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Gastroenterology & Hepatology

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21750513%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21750513%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21750513%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

425-426

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21750513%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrgastro.2011.117

7 February 2020

exact match

0 references

cites work

Pathology of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.117

Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.117

Treatment of nonalcoholic fatty liver disease in children: TONIC trial design

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.117

Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.117

Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.117

The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.117

Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.117

Nonalcoholic fatty liver disease in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.117

Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.117

Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21750513